The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Can Mounjaro Help With Lipedema?
Lipedema is a chronic condition affecting fat distribution, primarily in women, causing swelling and discomfort in the legs and arms. Some people with lipedema are exploring Mounjaro (tirzepatide), a prescription-only GLP-1 and GIP receptor agonist, as a potential management option alongside lifestyle changes. This guide explains what lipedema is, how Mounjaro works, and what UK healthcare professionals recommend about its use for lipedema specifically.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Understanding Lipedema and Weight Management
Lipedema is a progressive condition characterised by abnormal fat accumulation, typically in the legs, thighs, and sometimes arms and torso. Unlike standard obesity, lipedema involves disproportionate fat distribution, often causing pain, swelling, and reduced mobility. It predominantly affects women and is often misdiagnosed as simple overweight or obesity.
Lipedema differs from lymphoedema (fluid retention) and requires specialist assessment. Key features include: symmetrical swelling below the waist, pain and tenderness in affected areas, easy bruising, and fat that does not respond well to diet and exercise alone. Because lipedema involves abnormal fat distribution patterns, standard weight loss approaches may have limited effectiveness on affected areas, though reducing overall weight can help manage symptoms and reduce strain on joints.
Mounjaro works by activating GLP-1 and GIP hormone pathways, which may reduce appetite and support modest weight reduction. However, weight loss alone may not address the underlying lipedema pathology, and specialist assessment is essential before considering any medication.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro, Lipedema, and Current Evidence
There is limited clinical evidence specifically examining Mounjaro's effectiveness in lipedema management. Most clinical trial data on Mounjaro (the SURMOUNT trials) involved people with obesity or type 2 diabetes, not specifically those with lipedema. Individual lipedema experiences vary significantly, and what helps one person may not help another.
Some people with lipedema report that modest weight reduction through GLP-1 medication may ease symptoms like pain and mobility restrictions, but this is not assured. If you have lipedema and are considering Mounjaro, your GP or a specialist should assess whether this medication is appropriate for your individual situation. A lipedema specialist, dermatologist, or vascular specialist can advise on how weight management fits into your broader lipedema care plan, which may include compression therapy, lymphatic drainage, physiotherapy, and nutritional support.
Access to Mounjaro in the UK requires a prescription from a licensed healthcare professional following a clinical assessment. This can be through NHS specialist weight management services (typically tier 3 services) or private online prescribing services. Your prescriber will evaluate your personal health situation, including any existing lipedema diagnosis, before deciding if Mounjaro is suitable.
Use our free GLP-1 weight loss calculator to understand potential weight loss projections at different Mounjaro doses, though remember these are population averages and lipedema responses may differ. Our BMI calculator can also help track your weight status over time, complementing any lipedema management plan your healthcare team recommends.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro approved specifically for lipedema in the UK?
No. Mounjaro is licensed in the UK for weight management in adults with obesity or overweight with weight-related health conditions — not specifically for lipedema. If you have lipedema, your GP or specialist must assess whether Mounjaro is appropriate for your individual situation.
Can Mounjaro reduce lipedema swelling?
Mounjaro may support modest weight reduction, which could ease pain and improve mobility in some people with lipedema. However, lipedema involves abnormal fat distribution patterns that may not respond to weight loss alone. Evidence specific to lipedema is limited — specialist assessment is essential.
What's the difference between lipedema and obesity?
Lipedema is a distinct condition involving disproportionate, abnormal fat distribution, typically in the legs and thighs, often causing pain and swelling. It differs from standard obesity and is often hereditary. Standard weight loss approaches may have limited effect on lipedema-affected areas specifically.
Should I ask my GP about Mounjaro if I have lipedema?
Yes, discuss your lipedema diagnosis with your GP. However, you may benefit more from assessment by a lipedema specialist, dermatologist, or vascular specialist first. They can advise whether weight management medication fits into your broader lipedema care plan, which may include compression therapy and physiotherapy.
What is tirzepatide and how does it work?
Tirzepatide (brand name Mounjaro) is a dual GLP-1 and GIP receptor agonist that activates two natural hormone pathways involved in appetite regulation and blood sugar control. It may help reduce appetite and support weight reduction when combined with dietary changes and increased physical activity.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.